Search - tctmd.com

Displaying 1 - 20 of 536

Sort: Relevancy | Date

January 2026 Dispatch for the CV Team

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

January 16, 2026

Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke

News Daily News

Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke

January 07, 2026

Year in Review: Top Prevention Stories of 2025

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

December 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

December 23, 2025

Remission From Prediabetes Halves CV Risk: Registry Data

News Daily News

Remission From Prediabetes Halves CV Risk: Registry Data

Yael L. Maxwell

December 19, 2025

AHA Highlights Single-Pill Combo Therapy for Hypertension

News Daily News

AHA Highlights Single-Pill Combo Therapy for Hypertension

December 17, 2025

TCTMD’s Top 10 Most Popular Stories for November 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

December 01, 2025

November 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

November 24, 2025

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

News Conference News AHA 2025

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

Michael O'Riordan

November 14, 2025

Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids

News Conference News AHA 2025

Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids

Michael O'Riordan

November 10, 2025

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

News Conference News AHA 2025

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

Michael O'Riordan

November 08, 2025

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

News Conference News AHA 2025

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

November 08, 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

November 08, 2025

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

News Daily News

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

October 16, 2025

Bax24: Baxdrostat Successful Again, This Time in Resistant Hypertension

News Daily News

Bax24: Baxdrostat Successful Again, This Time in Resistant Hypertension

October 07, 2025

ACC: It’s Time for Clinicians to Address Inflammation in CVD

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

October 03, 2025

Evolocumab Wins for Primary Prevention in VESALIUS-CV

News Daily News

Evolocumab Wins for Primary Prevention in VESALIUS-CV

October 03, 2025

Risk Factors Present in Nearly All Patients Who Develop CVD

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

Recognize and Enable Care for Post-MI Psychological Distress: AHA

News Daily News

Recognize and Enable Care for Post-MI Psychological Distress: AHA

October 01, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.